152 results
Page 4 of 8
DEFA14A
vemtb ljgeb
24 Mar 21
Additional proxy soliciting materials
4:45pm
S-8
EX-23.1
1f40aaa
10 Mar 21
Registration of securities for employees
5:01pm
S-8
peb9x wwubq
10 Mar 21
Registration of securities for employees
5:01pm
8-K
EX-1.1
mlupritmpg
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
8-K
EX-99.2
powqfmiaudq x9
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
zapeqpmipb3x8 sd3v
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
ebxenuokb4
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
1c6a23
11 Dec 20
Other Events
5:06pm
8-K
EX-99.2
3n2 gv5rzlihc7z3
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
EX-99.1
mjr xc7n39v4bvum3dr
4 Nov 20
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
kc14u gspvcp
5 Aug 20
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:12pm
8-K
5r2kiedyhd8kctqtfa
2 Jul 20
Departure of Directors or Certain Officers
9:17am
8-K
os1q saazds7a
1 Jun 20
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
EX-99.2
j1c58
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm